# FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy

> **NCT02349945** · PHASE2,PHASE3 · COMPLETED · sponsor: **Azienda USL Modena** · enrollment: 88 (actual)

## Conditions studied

- Male Infertility

## Interventions

- **DRUG:** follitropin alpha

## Key facts

- **NCT ID:** NCT02349945
- **Lead sponsor:** Azienda USL Modena
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349945, "FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02349945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*